retatrutide suppliers for Weight Loss: TRIUMPH-1 Results, Cost, Insurance RETATRUTIDE - PeptiFactory – Peptide

Retatrutide (also called as Retatrutide acetate, LY3437943) is a next-generation metabolic peptide distinguished by its triple-agonist mechanism targeting GLP-1, GIP, and glucagon receptors simultaneously

Look AR, Wing RR

NEJM Dec 2025) 12 None (no approved label) MTC thyroid C-cell (rodent, human relevance unestablished) 28 None published None published Once weekly, subcutaneous Once weekly, subcutaneous US: late 2027 earliest (NDA Q4 2026 at soonest) 22 Already approved (US: 2022/2023/2024

How MeAgain tracks side effects differently Symptoms are part of the GLP-1 routine MeAgain does not treat side effects as a separate health diary